Funding for this research was provided by:
Science Foundation Ireland (14/IA/2582, 13/IA/1881)
Brain Tumor Ireland (-)
European Union’s Seventh Framework Programme for research, technological development, and demonstration (306021 (APO-DECIDE))
International Training Network supported by the European Union’s H2020 Programme for research (766069)
Text and Data Mining valid from 2019-11-12
Received: 1 May 2019
Accepted: 9 October 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: Tumor resections included in the analyses were obtained from the tissue bank at the Goethe University Hospital, Frankfurt, Germany. The use of patient material was approved by the local ethical committee (SNO-07-13), [CitationRef removed].
: Not applicable.
: JHMP filed a patent for the system model APOPTO-CELL showcased here (“A computer-implemented system and method for the prediction of cancer response to genotoxic chemotherapy and personalised neoadjuvant treatments (PCCP)”, Derwent primary accession number: 2013-A25393).